LTFS
LJPC

Ladenburg Thalmann Financial Services’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$38K Sell
9,795
-625
-6% -$3.69K ﹤0.01% 3720
2019
Q3 		$92K Buy
+10,420
New +$98.4K ﹤0.01% 2998
2018
Q3 		– Sell
-27
Closed -$1K – 5646
2018
Q2 		$1K Hold
27
– – ﹤0.01% 5085
2018
Q1 		$1K Hold
27
– – ﹤0.01% 5085
2017
Q4 		$1K Buy
+27
New +$882 ﹤0.01% 5009

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LJPC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its La Jolla Pharmaceutical Company (LJPC) stake by 6% in Q4 2019, selling an estimated $3.69K and leaving 9,795 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #3720.

Ladenburg Thalmann Financial Services first reported a position in LJPC in Q4 2017 and has held it in 5 quarters since. The position peaked at $92K in Q3 2019. 77 funds tracked by Wall St. Rank hold LJPC as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 9,795 shares of La Jolla Pharmaceutical Company worth $38K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 625 La Jolla Pharmaceutical Company shares in Q4 2019, an estimated $3.69K.
  • La Jolla Pharmaceutical Company made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3720 holding.
  • Ladenburg Thalmann Financial Services first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and has held it in 5 quarters since.
  • Ladenburg Thalmann Financial Services's La Jolla Pharmaceutical Company position peaked at $92K in Q3 2019.
  • 77 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.